Small interfering RNA efficiently suppresses adhesion molecule expression on pulmonary microvascular endothelium
Tobias Walker1, Julian Siegel, Andrea Nolte
1Department of Thoracic, Cardiac and Vascular Surgery, Tübingen University Hospital, Hoppe-Seyler-Straße 3, 72076 Tübingen, Germany.
Journal of Nucleic Acids
|October 7, 2011
Summary
Small interfering RNAs (siRNAs) effectively reduced adhesion molecule expression in human lung cells. This suppression diminished neutrophil attachment, suggesting potential for minimizing inflammatory responses after lung transplantation.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Adhesion molecules play a role in postoperative organ function and inflammatory responses.
- Ischemia-reperfusion injury involves inflammatory processes where adhesion molecules are implicated.
- Pulmonary microvascular endothelial cells are key players in lung inflammation and injury.
Purpose of the Study:
- To evaluate the efficacy of small interfering RNAs (siRNAs) in suppressing adhesion molecule expression.
- To investigate the impact of siRNA-mediated suppression on neutrophil adhesion to endothelial cells.
Main Methods:
- Human lung microvascular endothelial cells were transfected with specific siRNAs.
- Cells were stimulated with an inflammatory cytokine to induce an inflammatory response.
- Adhesion molecule expression was quantified using FACS analysis, and mRNA levels were measured by qRT-PCR.
- Neutrophil attachment to the endothelial cell layer was assessed post-transfection.
Main Results:
- siRNA transfection significantly decreased the expression of investigated adhesion molecules.
- A reduction in the percentage of positive cells for adhesion molecules was observed.
- The attachment of isolated neutrophils to the endothelial layer was significantly diminished.
Conclusions:
- siRNA represents a potent tool for suppressing adhesion molecule expression in pulmonary microvascular cells.
- This suppression may reduce leukocyte-endothelial interactions, potentially mitigating inflammatory damage in lung allografts.
- Further research into siRNA-based therapies could offer new strategies for managing post-transplant complications.
Related Concept Videos
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...


